BioWin is the regional reference player in the fields of health biotechnology and medical technologies.

The cluster gathers all the companies, universities and research centers involved in innovative R&D projects

supporting the development and the delivering of new

products and services to the global market.

BioWin’s strategic activities:• Regional&Internationalinnovative R&D projects

• International networking & partnering

(in Europe, China and the US)

• Trainingprogramsspecifictothebioindustry

• Supporttothecreationoftechnologicalplatforms

BioWin’s members are active in the followingkeytechnologicalareas:

• Biopharmacy

• Celltherapy&regenerativemedicine

• Immunology

• Diagnostics(in vitro & in vivo)

• Radiationapplicationsinhealthcare

• Instruments&medicaldevices

• Biotechproducts&services

www.biowin.org

Our members are active in the following key technological areas:

• Biopharmacy

• Cell therapy & Regenerative medicine

• Immunology

• Diagnostics (in vitro & in vivo)

• Radiation applications in healthcare

• Instruments & medical devices

• Biotech products and services

© M

asTH

erCe

ll 2

01

3

BioWin, your gateway to health biotech and medtech excellence

WWW.BIOWIN.ORG

CONTACT BIOWIN NOW TO FIND YOUR SCIENCE AND/OR BUSINESS PARTNER IN WALLONIA!

BIOW-14-14193-Annonce Presse-cr-080914-bat.indd 1 8/09/14 16:12

The place to innovate in life sciences

InvestinWallonia

Wallonia Export - Investment Agency Forexport:f.kania@awex.be

Forforeigninvestment:pjanssens@investinwallonia.be

(T) +32 81 33 28 50

www.investinwallonia.be AW

EX

10

/20

14

Wallonia Export - Investment Agency, yourgatewaytoWallonia - Europe

WalloniaExport-InvestmentAgencyisyourone-stopshop

andpartnerstartingfromtheveryonsetofyourstudies

andEuropeandevelopment.Withus,you’llfindscientific,

fiscal and business expertise to prepare, launch or develop

youractivities.Withus,you’llfindthekeythatopensthe

door to academic, scientific and industrial networks.

BiowinjoinsWalloniaExport-InvestmentAgencytocreate

ateamofspecialistsdedicatedtoyourproject.

Contact us!London

Amsterdam

FrankfurtParis

BrusselsWallonia

R&Dincentives

Keyinformation(Wallonia, sectors,...)

Talents recruitment & training

Businessplan

Site selection

Multilingualsector experts

Tax & legalassistance

Wallonia - Belgium The place to innovate in life sciences

Wallonia, the southernmost region of Belgium, has

developed itself into a center of life science companies

through major investments in R&D. The ongoing efforts

to improve the business environment in the region have

allowed companies to improve their competitiveness

through lower costs and easier access to facilities and

qualified workforce. Furthermore, companies have been

largelybenefiting from the financial support offered by Wallonia in the form of R&D subsidies, advances and tax reduction for research.

LondonAmsterdam

FrankfurtParis

BrusselsWallonia

7 key reasons tolocateinWallonia:

• Unique location attheveryheartofEurope• European leader in clinical research• Favorable tax environment and R&D incentives • Biotechhub connected with first-class clusters and organisations worldwide• Top capacities to develop and deliver innovative

products&servicesfrombenchtomarketinkeyareas

• Worldwide leaders trust us: GSK, IBA, Zoetis,... • Biolog Europe,afacilitatorinSupplyChain Management (SCM)

We are now at a stage where our production capacity

must increase to INDUSTRIAL SCALE and we look

forward to moving all our operations to these cutting-edge,

high-techpremises :theWalloonCellTherapyPlatformat

the new Biopark Charleroi Brussels South

Enrico BASTIANELLICEO of Bone Therapeutics

“

”

Wallonia is the excellent place for investments in the Life

Sciences sector because there is a dense network of biotech companies and universities with activities in life sciences.

Moreover, the Walloon Government has made a strategic

decision to support the implementation and development

of companies with tax incentives and direct financial

support through the Biowin cluster to collaborative research

projectsbetweenIndustryandAcademia

Takamune YASUDACOO, Eurogentec (KANEKA Group)

“

”

We are delighted to PARTICIPATE in the Walloon

Cell Therapy Platform project, that has been made

possibleby theWalloonRegion,whichhas supportedus

from the outset. This partnership allows us to pool resources

and increase efficiencywhilerespectingeachcompany’s

know-howandintellectualproperty

Eric HALIOUA CEOofPrometheraBiosciences

“

”

The four large universities are playing a part in the

industrialredeployment.Thevice-chancellorsnowconsider

they have a part to play in economic development.

Consequently, the universities are closer to market requirements and current industrial developments.Theyseechangepositively,andliketheSMEs,wanttocontribute

to it. The success of centres of competitiveness will not be

abletomaterializewithoutaclosesynergybetweenallthe

players

Jean STÉPHENNEFormer CEO and Chairman of GSK

“

”

Wallonia is ideally located for shippingbyroadto our two major markets, FranceandGermany,and isclose to

the freight airports at Liege and Brussels. The region has

the support of the public authorities and all of the workforce

weneedisavailable.Ourteamswork7daysaweek,which

enablesustohandleanaverageof4,000ordersaday

Jean-Michel COLNOT Operations Director, Johnson & Johnson

“

”

Wallonia, whatyoushouldknow & what theplayersaresaying

Choosing La Louvière and Wallonia in general for setting

upournewdistributioncentrewasmadeeasybyitslocationat

theeveryheartofseveralmajormarkets,andbyafavourable

network of road, railway and airport transport systems.

Moreover, Belgian scientific know-how in thepharmaceutical

sector, in addition to a “highly competitive tax climate

were also decisive factors

Dirk COLLIER CorporatesecretaryofJanssenPharmaceutica

(J&J Group)

“

”

€